nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—Methocarbamol—CA1—esophageal cancer	0.135	0.771	CrCbGaD
Alprenolol—Atenolol—ABCB1—esophageal cancer	0.0129	0.074	CrCbGaD
Alprenolol—Acebutolol—ABCB1—esophageal cancer	0.0119	0.0683	CrCbGaD
Alprenolol—Metoprolol—ABCB1—esophageal cancer	0.0101	0.0577	CrCbGaD
Alprenolol—Propranolol—ABCB1—esophageal cancer	0.00509	0.0291	CrCbGaD
Alprenolol—ADRB1—GPCR ligand binding—GHRL—esophageal cancer	0.0016	0.00194	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—WIF1—esophageal cancer	0.0016	0.00194	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—SST—esophageal cancer	0.00157	0.00191	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL2—esophageal cancer	0.00157	0.0019	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—GHRL—esophageal cancer	0.00157	0.0019	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—SST—esophageal cancer	0.00157	0.0019	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—GHRL—esophageal cancer	0.00153	0.00186	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—GHRL—esophageal cancer	0.00153	0.00185	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.00152	0.00184	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.0015	0.00182	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CSNK1A1—esophageal cancer	0.00148	0.00179	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ANXA1—esophageal cancer	0.00146	0.00177	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.00143	0.00173	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—SST—esophageal cancer	0.00142	0.00172	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00141	0.00171	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—GHRL—esophageal cancer	0.00139	0.00168	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PFN1—esophageal cancer	0.00138	0.00167	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKAP13—esophageal cancer	0.00134	0.00162	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKAP13—esophageal cancer	0.00131	0.00159	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKAP13—esophageal cancer	0.00128	0.00155	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KMT2D—esophageal cancer	0.00125	0.00152	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ELMO1—esophageal cancer	0.00124	0.0015	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PDE4D—esophageal cancer	0.00123	0.00149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KMT2D—esophageal cancer	0.00122	0.00148	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKAP13—esophageal cancer	0.00122	0.00148	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKAP13—esophageal cancer	0.00121	0.00147	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.0012	0.00146	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PDE4D—esophageal cancer	0.0012	0.00145	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KMT2D—esophageal cancer	0.0012	0.00145	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKAP13—esophageal cancer	0.00119	0.00144	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PDE4D—esophageal cancer	0.00117	0.00142	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GNG7—esophageal cancer	0.00117	0.00141	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKAP13—esophageal cancer	0.00116	0.00141	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GNG7—esophageal cancer	0.00114	0.00138	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00112	0.00135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADCYAP1—esophageal cancer	0.00112	0.00135	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GNG7—esophageal cancer	0.00112	0.00135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PDE4D—esophageal cancer	0.00111	0.00135	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PDE4D—esophageal cancer	0.00111	0.00134	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADCYAP1—esophageal cancer	0.00109	0.00132	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PDE4D—esophageal cancer	0.00109	0.00132	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADCYAP1—esophageal cancer	0.00107	0.00129	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PDE4D—esophageal cancer	0.00107	0.00129	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GNG7—esophageal cancer	0.00106	0.00128	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GNG7—esophageal cancer	0.00105	0.00128	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GNG7—esophageal cancer	0.00104	0.00126	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL2—esophageal cancer	0.00103	0.00125	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—WWOX—esophageal cancer	0.00102	0.00124	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GNG7—esophageal cancer	0.00101	0.00123	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL2—esophageal cancer	0.00101	0.00122	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—WWOX—esophageal cancer	0.000999	0.00121	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—XIAP—esophageal cancer	0.000988	0.0012	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000983	0.00119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—WWOX—esophageal cancer	0.000976	0.00118	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FKBP1A—esophageal cancer	0.000971	0.00118	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000955	0.00116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FKBP1A—esophageal cancer	0.00095	0.00115	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—WIF1—esophageal cancer	0.000949	0.00115	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000934	0.00113	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CTNNA1—esophageal cancer	0.000934	0.00113	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL2—esophageal cancer	0.000933	0.00113	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—SST—esophageal cancer	0.000929	0.00113	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FKBP1A—esophageal cancer	0.000929	0.00113	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL2—esophageal cancer	0.000929	0.00113	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—WIF1—esophageal cancer	0.000928	0.00112	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000914	0.00111	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL2—esophageal cancer	0.000913	0.00111	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—SST—esophageal cancer	0.000909	0.0011	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—WIF1—esophageal cancer	0.000908	0.0011	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GHRL—esophageal cancer	0.000906	0.0011	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL2—esophageal cancer	0.000893	0.00108	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—SST—esophageal cancer	0.000889	0.00108	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GHRL—esophageal cancer	0.000886	0.00107	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000876	0.00106	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PSME2—esophageal cancer	0.000868	0.00105	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PSME1—esophageal cancer	0.000868	0.00105	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ANXA1—esophageal cancer	0.000867	0.00105	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GHRL—esophageal cancer	0.000866	0.00105	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ANXA1—esophageal cancer	0.000863	0.00105	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000857	0.00104	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ANXA1—esophageal cancer	0.000849	0.00103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—SST—esophageal cancer	0.000844	0.00102	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SST—esophageal cancer	0.00084	0.00102	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CSNK1A1—esophageal cancer	0.000838	0.00102	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ANXA1—esophageal cancer	0.00083	0.00101	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—SST—esophageal cancer	0.000825	0.001	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GHRL—esophageal cancer	0.000822	0.000996	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PFN1—esophageal cancer	0.000819	0.000993	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOTCH3—esophageal cancer	0.000818	0.000992	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GHRL—esophageal cancer	0.000818	0.000992	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—SST—esophageal cancer	0.000807	0.000978	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—FBXW7—esophageal cancer	0.000805	0.000976	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GHRL—esophageal cancer	0.000804	0.000975	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PFN1—esophageal cancer	0.000801	0.000971	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GHRL—esophageal cancer	0.000787	0.000953	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PFN1—esophageal cancer	0.000784	0.000949	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000769	0.000932	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000769	0.000932	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ELMO1—esophageal cancer	0.000736	0.000892	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOTCH2—esophageal cancer	0.000734	0.00089	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ELMO1—esophageal cancer	0.00072	0.000872	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKAP13—esophageal cancer	0.000719	0.000871	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ELMO1—esophageal cancer	0.000704	0.000853	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKAP13—esophageal cancer	0.000704	0.000852	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKAP13—esophageal cancer	0.000688	0.000834	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000664	0.000804	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDE4D—esophageal cancer	0.000658	0.000797	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CA1—esophageal cancer	0.000654	0.000792	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000654	0.000792	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFBR2—esophageal cancer	0.000651	0.000789	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000649	0.000787	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDE4D—esophageal cancer	0.000643	0.00078	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000635	0.000769	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDE4D—esophageal cancer	0.000629	0.000762	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GNG7—esophageal cancer	0.000626	0.000758	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SMAD4—esophageal cancer	0.000616	0.000747	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GNG7—esophageal cancer	0.000612	0.000742	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GNG7—esophageal cancer	0.000598	0.000725	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CA2—esophageal cancer	0.000598	0.000725	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—XIAP—esophageal cancer	0.000586	0.00071	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—XIAP—esophageal cancer	0.000574	0.000695	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—XIAP—esophageal cancer	0.000561	0.00068	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000556	0.000674	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000556	0.000674	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CTNNA1—esophageal cancer	0.000554	0.000672	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL2—esophageal cancer	0.000551	0.000668	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CTNNA1—esophageal cancer	0.000542	0.000657	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL2—esophageal cancer	0.000539	0.000653	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CTNNA1—esophageal cancer	0.00053	0.000643	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL2—esophageal cancer	0.000527	0.000639	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PSME2—esophageal cancer	0.000515	0.000624	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PSME1—esophageal cancer	0.000515	0.000624	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ANXA1—esophageal cancer	0.000512	0.000621	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HIF1A—esophageal cancer	0.000504	0.000611	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PSME2—esophageal cancer	0.000504	0.00061	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PSME1—esophageal cancer	0.000504	0.00061	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ANXA1—esophageal cancer	0.000501	0.000607	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SST—esophageal cancer	0.000499	0.000604	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PSME1—esophageal cancer	0.000493	0.000597	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PSME2—esophageal cancer	0.000493	0.000597	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	0.00049	0.000594	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SST—esophageal cancer	0.000488	0.000591	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000488	0.000591	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GHRL—esophageal cancer	0.000486	0.000589	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH3—esophageal cancer	0.000486	0.000589	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—KDR—esophageal cancer	0.000482	0.000585	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FBXW7—esophageal cancer	0.000478	0.000579	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SST—esophageal cancer	0.000477	0.000578	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH3—esophageal cancer	0.000475	0.000576	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GHRL—esophageal cancer	0.000475	0.000576	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FBXW7—esophageal cancer	0.000468	0.000567	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000466	0.000565	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GHRL—esophageal cancer	0.000465	0.000563	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000465	0.000563	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	0.000457	0.000554	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOTCH1—esophageal cancer	0.000454	0.000551	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000453	0.000549	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000442	0.000535	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH2—esophageal cancer	0.000436	0.000528	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH2—esophageal cancer	0.000426	0.000516	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000421	0.000511	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000421	0.000511	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000417	0.000505	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CREBBP—esophageal cancer	0.000412	0.000499	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—EGFR—esophageal cancer	0.000405	0.000491	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000404	0.000489	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000389	0.000471	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000387	0.000469	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFBR2—esophageal cancer	0.000387	0.000468	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000385	0.000467	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFBR2—esophageal cancer	0.000378	0.000458	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	0.00037	0.000448	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOS3—esophageal cancer	0.000369	0.000447	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000367	0.000444	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SMAD4—esophageal cancer	0.000366	0.000443	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SMAD4—esophageal cancer	0.000358	0.000434	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PIK3CA—esophageal cancer	0.000351	0.000426	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	0.00035	0.000424	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ERBB2—esophageal cancer	0.000345	0.000418	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000343	0.000416	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000327	0.000396	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000323	0.000391	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000306	0.000371	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000306	0.000371	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCND1—esophageal cancer	0.000305	0.000369	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000302	0.000366	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000302	0.000366	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HIF1A—esophageal cancer	0.000299	0.000363	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CDKN1A—esophageal cancer	0.000295	0.000357	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HIF1A—esophageal cancer	0.000293	0.000355	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	0.000286	0.000347	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KDR—esophageal cancer	0.000286	0.000347	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EP300—esophageal cancer	0.000281	0.00034	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KDR—esophageal cancer	0.00028	0.000339	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KDR—esophageal cancer	0.000274	0.000332	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH1—esophageal cancer	0.00027	0.000327	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH1—esophageal cancer	0.000264	0.00032	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.00026	0.000315	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000258	0.000313	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP19A1—esophageal cancer	0.000245	0.000297	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CREBBP—esophageal cancer	0.000245	0.000296	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MYC—esophageal cancer	0.000245	0.000296	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—EGFR—esophageal cancer	0.00024	0.000291	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CREBBP—esophageal cancer	0.000239	0.00029	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EGFR—esophageal cancer	0.000239	0.00029	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—EGFR—esophageal cancer	0.000235	0.000285	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	0.000234	0.000283	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	0.00023	0.000279	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00023	0.000278	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000225	0.000272	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—esophageal cancer	0.000223	0.000271	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.00022	0.000266	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—esophageal cancer	0.000219	0.000265	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCB1—esophageal cancer	0.000214	0.00026	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—esophageal cancer	0.000214	0.00026	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—esophageal cancer	0.000209	0.000254	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000209	0.000253	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CA—esophageal cancer	0.000208	0.000252	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ERBB2—esophageal cancer	0.000205	0.000248	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000204	0.000247	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—esophageal cancer	0.000201	0.000243	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ERBB2—esophageal cancer	0.0002	0.000243	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000199	0.000242	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	0.000196	0.000237	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCND1—esophageal cancer	0.000181	0.000219	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCND1—esophageal cancer	0.000177	0.000214	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CDKN1A—esophageal cancer	0.000175	0.000212	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCND1—esophageal cancer	0.000173	0.00021	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CDKN1A—esophageal cancer	0.000171	0.000207	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	0.000167	0.000203	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EP300—esophageal cancer	0.000167	0.000202	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EP300—esophageal cancer	0.000163	0.000197	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EP300—esophageal cancer	0.000159	0.000193	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MYC—esophageal cancer	0.000145	0.000176	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CREBBP—esophageal cancer	0.000143	0.000174	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MYC—esophageal cancer	0.000142	0.000172	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EGFR—esophageal cancer	0.000142	0.000172	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EGFR—esophageal cancer	0.000139	0.000168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MYC—esophageal cancer	0.000139	0.000168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EGFR—esophageal cancer	0.000136	0.000165	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—esophageal cancer	0.000128	0.000155	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CA—esophageal cancer	0.000123	0.000149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CA—esophageal cancer	0.000121	0.000146	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—esophageal cancer	0.000119	0.000144	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	0.000118	0.000143	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—esophageal cancer	0.000117	0.000142	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—esophageal cancer	0.000117	0.000141	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—esophageal cancer	0.000114	0.000138	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EP300—esophageal cancer	9.76e-05	0.000118	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CA—esophageal cancer	7.22e-05	8.75e-05	CbGpPWpGaD
